Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
483 Leser
Artikel bewerten:
(2)

HIMSS: New Report Sheds Light on Japan's Digital Healthcare Economy

Commonalities between the UK and Japan exist, and a new whitepaper gives insights into the areas of data, digitisation and collaboration

LONDON, Sept. 30, 2019." It is authored by Professor Sudhesh Kumar, Dean of Warwick Medical School at the University of Warwick.

Key findings:

  • Japan shares some common traits with the UK in healthcare and society. It provides universal health care and, being mature, developed economies, face an aging demographic trend. 28.1% of the total Japanese population is aged 65 and over; 13.9% of the total population was 65 - 74, 14.2% was 75-year-old and over.
  • Japanese healthcare market, the world's second largest for pharmaceutical products, medical devices and healthcare services, is characterised by an abundance of data, generated from the citizens of more than 126 million which its healthcare system covers. It includes health care insurance claims, healthcare records from regulatory annual health check-ups, and data regarding nursing care through its Long-Term Care Insurance (LTCI) system.
  • Japan has recently started harnessing those data for digitalisation of its healthcare services to create of its Next-Generation Healthcare System with introducing advanced technology. The government has introduced a new law to make the data make more useful to research institutions and private-sector companies for the purpose of advanced research, innovative drug discovery, and new business creation.
  • Japan's unique data set that reflects the world's leading ageing population, coupled with the recent transformative policy, would be invaluable to testing innovations that will be in high demand across the world as other countries follow in the super-aging trend. The UK's joint research programme with Japan announced this January to help ageing populations live independently for longer and to develop new treatments for chronic conditions like dementia and heart failure might be a precursor. As the UK is more advanced than Japan in terms of digital healthcare, partnership in this field by the two counties can harness unprecedented potential to resolve some of big problems of today's humankind and lead a new digital healthcare economy during this era of ageing societies.

About the author:
Professor Sudhesh Kumar is Dean of the Warwick Medical School and Director of the Institute of Digital Healthcare at University of Warwick. In addition to these roles, he is also a member of the Coventry & Rugby Health and Wellbeing Board, and the Medical Schools Council. He is a clinical endocrinologist by background with 22 years experience as a Consultant Physician in the NHS. His research interest is obesity and its complications, particularly Type 2 diabetes. His interests include developing novel approaches to managing obesity and diabetes that has helped to transform and improve patient care and treatment. He has published over 240 papers and 6 books on these subjects.

About HIMSS
HIMSS is a global advisor and thought leader supporting the transformation of the health ecosystem through information and technology. As a mission driven non-profit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and analytics to advise global leaders, stakeholders and influencers on best practices in health information and technology. Through our innovation engine, HIMSS delivers key insights, education and engaging events to healthcare providers, governments and market suppliers, ensuring they have the right information at the point of decision. Headquartered in Chicago, Illinois, HIMSS serves the global health information and technology communities with focused operations across North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. Our members include more than 80,000 individuals, 475 provider organizations and 650 health services organizations.

© 2019 GlobeNewswire (Europe)
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.